Jeff Aronin’s Paragon Biosciences Helps People Live Longer And Healthier

Paragon Biosciences led by Jeff Aronin is more than just an investment firm, they support biotech companies that use technology to help people live longer and healthier lives. Their unique approach has resulted in 13 new life-saving medications, leaving many to wonder just how they do it. Paragon Biosciences has a three step process that helps them bring the most promising innovations to those in need.

First, they focus on a problem. They look at those illnesses where patient need is at an all-time high. They also consider the unavailability of treatment, because they want to provide solutions where there seems little promise from other sources (Crunchbase). In looking at these conditions, the company researches how the illnesses affect patients and what the medical community is currently doing to treat them.

Next, Paragon Biosciences builds a company around the need for a solution to the particular disease. That means investing resources in researchers, but it also means formulating a business model that will be sustainable for investors. Each company is managed by a team comprised of healthcare professionals and entrepreneurs from the biotech field. This helps to ensure researcher proposals are viable for the company to pursue.

Finally, the new company gets to work on a cure or treatment. They employ state of the art technology and the latest scientific advances to come up with new treatments for the illness that is the company’s focus. This is how Paragon brings innovative new treatments to some of the most destructive diseases facing today’s society.


Jeff Aronin is the Man Behind the Vision

Since 2010, it has been Jeff Aronin at the helm of Paragon Biosciences. He currently serves as both the company’s chairman and CEO, positions he has held for the past eight years. Prior to that, Jeff founded his own biopharmaceutical company, Ovation Pharmaceuticals Inc., in 2000. Mr. Aronin served as the president and chief executive officer of that company for nine years, before taking his position with Paragon.

Jeff’s experience has given him an edge that compliments Paragon’s vision. In addition to possessing a keen eye for financial investments and a talent for brand marketing, Aronin is experienced in developing promising strategies for business development. That collection of expertise helps Mr. Aronin recognize the most promising projects for Paragon to undertake. Under Jeff Aronin’s leadership, Paragon continues to create promising new biotech companies that promise hopeful new treatments to some of the world’s most perplexing illnesses.

Jeff Aronin: The Voice Behind Paragon Biosciences Company’s Growth

Paragon Biosciences is an investor and incubator company that grows and builds companies in the line of biotechnology. Their focus is to address the needs of a patient, understand the science about the infection, and once that is done, they establish companies that will cater to the unmet needs of the patients. Through this, a successful drug development model is drawn helping in fast approval of significant medicines. Paragon Bioscience says that there are over 6,000 infections that have not found treatment, and that is why they are motivated to reducing the numbers. Jeff Aronin, the chairman and the chief executive officer of Paragon Biosciences, says that they are solving problems that have been rendered unsolvable by many people in the industry. Some of the companies that Paragon Biosciences has developed over time include Castle Creek Pharmaceuticals under the innovative biotechnological companies and they are developing therapies for patients who have rare dermatologic conditions. Harmony Biosciences is the other company that focuses on innovative drugs in meeting the needs of patients with sleep and central nervous system problems. Decade Company is focused on research and development for Alzheimer’s disease. Finally, the Precision BP treat and researches oncology infections.

Jeff Aronin has remained the chief executive officer for Paragon Biosciences since 2010. He founded the company in the year 2009. Alongside Paragon Biosciences, Jeff Aronin serves as a special advisor for Merrick Ventures ( He as well-founded Lundbeck Inc. in 2000 where he was the chief executive officer. Jeff Aronin has an MBA from DePaul University and a BS from Northern Illinois University.

Jeff has great experience in running most of the global pharmaceutical companies with extensive skills in finance, brand marketing, and business development. He is one of the rich people in wisdom, experience and knowledge in leadership that is necessary for each day management and the movement of a global company. Jeff is not limited to skills since he strongly structures and executes strategies for corporate transactions such as the mergers and acquisitions. This is all the companies need to make a big step in the market world regardless of the sector and specialization. With fruitful efforts, Jeff has been in a position to create transformation in the medical world more so in research and drug development industry.

Check Jeff Aronin’s (LinkedIn) account.